Tuesday, November, 24, 2009

Multiple Sclerosis Home >
SharePosts >
Living With It >
Lisa Emrich >
How to Manage Multiple Sclerosis Relapse: The Use of Solumedrol

Font size
- A
- A
- A
Email This

Receive a FREE Osteoarthritis of the knee pamphlet. Start here.

How to Manage Multiple Sclerosis Relapse: The Use of Solumedrol

Lisa Emrich Living With It Musician, Patient Advocate, and Founder - Carnival of MS Bloggers Lisa Emrich is a professional musician. She happens to live with... Send Message Subscribe: Lisa Emrich

Tuesday, May 12, 2009
View All of Lisa Emrich's Posts

SOURCES:
Practical Insights for Multiple Sclerosis Patients, MS Perspectives, Fall 2008

“Exacerbations” as discussed by National Multiple Sclerosis Society.

“Corticosteroids” as discussed by National Multiple Sclerosis Society.

“Solumedrol” as discussed by National Multiple Sclerosis Society.

For Further Information:
MS Essentials 01: Managing Relapses presented by MS Society UK, 2007.

You can read more of Lisa's writings at Brass and Ivory.

< Previous 1 | 2 | Page 3 >

View comments (19) | Add comment

Font size
- A
- A
- A
Email This

Bookmark
Thank you for your input

Save
RSS
Report Abuse

Ask a Question

Get answers from our experts and community members.

View all questions (1020) >

Related Multiple Sclerosis Topics

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MultipleSclerosisCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.